Author

P. Flynn

Observed institutions: Abbott Northwestern Hospital, Mayo Clinic, Genentech, University of Chicago, Missouri Valley Cancer Consortium, Rocky Mountain Cancer Centers, Mayo Clinic in Florida

OpenAlex ID: A5007370559

Efficacy of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE)

2006 · M. Kozloff, J. Hainsworth, et al. · Journal of Clinical Oncology · 26

Translational correlates, including outcome for patients with ER-/PR-/HER2- (triple negative (TNeg)) disease from N0234, a phase II trial of gemcitabine and erlotinib for pts with previously treated metastatic breast cancer (MBC)

2007 · S. Thome, T. Hobday, et al. · Journal of Clinical Oncology · 3

Authors & Collaborators _ RAISE study

2015 · Palazzo F. O 'connor, Pérez Je, et al.

Works count: 3

Citation count: 29

H-index: 2

I10-index: 1